FOND PER LISTITUTO ONCOLOGICO DI RICERCA IOR has a total of 11 patent applications. Its first patent ever was published in 2018. It filed its patents most often in Italy, United States and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are TIANJIN INT JOINT ACADEMY BIOMEDICINE, NEUROGENETIC PHARMACEUTICALS INC and BENEVOLENTAI BIO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | Italy | 3 | |
#2 | United States | 3 | |
#3 | EPO (European Patent Office) | 2 | |
#4 | WIPO (World Intellectual Property Organization) | 2 | |
#5 | China | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology | |
#4 | Measurement | |
#5 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Heterocyclic compounds | |
#4 | Specific use of cosmetics | |
#5 | Enzymes | |
#6 | Measuring microorganism processes | |
#7 | Microorganisms | |
#8 | Peptides | |
#9 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Alimonti Andrea | 7 |
#2 | Colucci Manuel | 6 |
#3 | Revandkar Ajinkya | 6 |
#4 | Guala Matilde | 4 |
#5 | Gaudio Eugenio | 4 |
#6 | Pazzi Natalina | 4 |
#7 | Bertoni Francesco | 4 |
#8 | Calcinotto Arianna | 1 |
#9 | Chen Jingjing | 1 |
#10 | D'Ambrosio Mariantonietta | 1 |
Publication | Filing date | Title |
---|---|---|
US2020095314A1 | Enhancement of prostate cancer treatment | |
WO2019142097A1 | Inhibitors of cxcr4 against senescence | |
EP3774793A1 | New compounds with enhanced anti-tumor effects | |
IT201800003818A1 | NEW PROSENESCENCE DRUGS | |
IT201800001168A1 | NEW SENOLYTIC DRUGS INHIBITORS ALK |